<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="27192">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02752737</url>
  </required_header>
  <id_info>
    <org_study_id>Cryo AF Global Registry</org_study_id>
    <nct_id>NCT02752737</nct_id>
  </id_info>
  <brief_title>Cryo AF Global Registry</brief_title>
  <official_title>Cryo AF Global Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Atrial Fibrillation Solutions</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Atrial Fibrillation Solutions</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cryo AF Global Registry a prospective, global, multi-center, observational Post-Market
      Registry
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Cryo AF Global Registry is a prospective, global, multi-center, observational
      post-market registry (PMR). The purpose of this study is to evaluate and describe clinical
      performance and safety data in a broad patient population treated with a commercially
      available Arctic Front™ Family of Cardiac Cryoablation Catheters (hereafter referred to as
      &quot;Arctic Front™ Cardiac Cryoablation Catheter System&quot;). The cryoballoon ablation(CBA)
      procedure will be performed according to routine hospital practice. The study is expected to
      have a 24 month enrollment period. The follow up period is intended to align with standard
      practice and subjects will be followed for a minimum of 12 months post-procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Freedom from Atrial Fibrillation (AF) Recurrence at 12 Months</measure>
    <time_frame>12 Months</time_frame>
    <description>Estimate the 12 month freedom from AF recurrence using the Arctic Front™ Cardiac Cryoablation Catheter System</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedom from Atrial Arrhythmia at 12 Months</measure>
    <time_frame>12 Months</time_frame>
    <description>Estimate the 12 month freedom from AF / Atrial Flutter (AFL)/ Atrial Tachycardia (AT) using the Arctic Front™ Cardiac Cryoablation Catheter System.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Freedom from Device / Procedure Related Adverse Events</measure>
    <time_frame>12 Months</time_frame>
    <description>Estimate device and procedure-related adverse events for cryoablation using the Arctic Front™ Cardiac Cryoablation Catheter System through 12 months.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Atrial Fibrillation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects 18 years or older with a planned procedure using commercially available Arctic
        Front™ Cardiac Cryoablation Catheter.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is ≥ 18 years of age or minimum age as required by local regulations

          -  Planned procedure using commercially available Arctic Front™ Cardiac Cryoablation
             Catheter

          -  Willing to comply with study requirements and give informed consent (defined as
             legally effective, documented confirmation of a subject's voluntary agreement to
             participate in this clinical study) or authorization per institution and geographical
             requirements

        Exclusion Criteria:

          -  Subject is enrolled in a concurrent study that has not been approved for concurrent
             enrollment by the global study manager

          -  Subject with exclusion criteria required by local law
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lauren Hemingway</last_name>
    <phone>6124010458</phone>
    <email>lauren.hemingway@medtronic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fred Ecklund</last_name>
    <phone>7635266839</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institituo Cardiovascular Buenos Aires (ICBA)</name>
      <address>
        <city>Buenos Aires</city>
        <zip>CP:1428</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Scazzuso, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Fundación Favaloro</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Luis Gonzalez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Ces</name>
      <address>
        <city>Medellin</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Uribe Arango, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saiseikai Kumamoto Hospital</name>
      <address>
        <city>Kumamoto</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ken Okumura, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Angeles Lomas</name>
      <address>
        <city>Huixquilucan</city>
        <zip>52763</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Fabregat Ramirez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital San Angel Inn Universidad</name>
      <address>
        <city>Mexico</city>
        <zip>03330</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerado Rodriguez Diez, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Colombia</country>
    <country>Japan</country>
    <country>Mexico</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 20, 2017</lastchanged_date>
  <firstreceived_date>April 25, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
